Projects and products
The knowledge of the role played by non-neuronal cells (Mast cells and Microglia) offers new perspectives on the management of conditions such as Neuroinflammation and Pain; these so far considered as the result of primary alteration of the nerve conduction, both at peripheral and central level.
A new pharmacology controlling Neuroinflammation and Pain (Inflammatory/Neuropathic pain) emerges, and it is based on the natural modulation of the Mast cell, localized in the peripheral tissues, and the Microglia (spinal sensitivity regulator).
Epitech neuroscience project aims to intervene on the non-neuronal cells (Mast cell and Microglia)while respecting the ALIA (Autocoid Local Injury Antagonism) physiology.
Cerebral Neuroinflammation represents a common feature to the chronic disorders affecting the Central Nervous System, as the case of neurodegenerative and traumatic diseases. In their complexity, the currently available knowledge suggests that a modulation approach to the non-neuronal cells (Astrocytes, Microglia and Mast cell) and to brain oxidative phenomena, could give a significant contribution in terms of prevention (in at-risk subjects) and slow down of neurodegenerative diseases.